1. Home
  2. PDLB vs VYGR Comparison

PDLB vs VYGR Comparison

Compare PDLB & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.87

Market Cap

393.1M

Sector

N/A

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.39

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
VYGR
Founded
1960
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
393.1M
232.4M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
PDLB
VYGR
Price
$16.87
$4.39
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.00
AVG Volume (30 Days)
69.1K
474.3K
Earning Date
01-27-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
142.83
N/A
EPS
0.89
N/A
Revenue
$96,252,000.00
$31,316,000.00
Revenue This Year
$10.97
N/A
Revenue Next Year
$8.59
$71.78
P/E Ratio
$18.98
N/A
Revenue Growth
26.04
N/A
52 Week Low
$10.88
$2.65
52 Week High
$16.99
$6.55

Technical Indicators

Market Signals
Indicator
PDLB
VYGR
Relative Strength Index (RSI) 70.16 54.46
Support Level $15.65 $3.74
Resistance Level $16.09 $4.51
Average True Range (ATR) 0.35 0.21
MACD 0.10 0.06
Stochastic Oscillator 99.72 84.94

Price Performance

Historical Comparison
PDLB
VYGR

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: